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Mechanisms of Vasovagal Syncope in the Young: Reduced Systemic
Vascular Resistance Versus Reduced Cardiac Output
Julian M. Stewart, MD, PhD; Marvin S. Medow, PhD; Richard Sutton, MB, BS, DSc; Paul Visintainer, PhD; David L. Jardine, FRACP, MD;
Wouter Wieling, MD, PhD
Background-—Syncope is a sudden transient loss of consciousness and postural tone caused by cerebral hypoperfusion. The most
common form is vasovagal syncope (VVS). Presyncopal progressive early hypotension in older VVS patients is caused by reduced
cardiac output (CO); younger patients have reduced systemic vascular resistance (SVR). Using a priori criteria for reduced CO (↓CO)
and SVR (↓SVR), we studied 48 recurrent young fainters comparing subgroups of VVS with VVS-↓CO, VVS-↓SVR, and both VVS-
↓CO&↓SVR.
Methods and Results-—Subjects were studied supine and during 70-degrere upright tilt with a Finometer to continuously measure
blood pressure, CO, and SVR and impedance plethysmography to estimate thoracic, splanchnic, pelvic, and calf blood volumes,
blood flows, and vascular resistances and electrocardiogram to measure heart rate and rhythm. Central blood volume was
decreased in all VVS compared to control. VVS-↓CO was associated with decreased splanchnic blood flow and increased
splanchnic blood pooling compared to control. Seventy-five percent of VVS patients had reduced SVR, including 23% who also had
reduced CO. Many VVS-↓SVR increased CO during tilt, with no difference in splanchnic pooling, caused by significant increases in
splanchnic blood flow and reduced splanchnic resistance. VVS-↓CO&↓SVR patients had splanchnic pooling comparable to VVS-↓CO
patients, but SVR comparable to VVS-↓SVR. Splanchnic vasodilation was reduced, compared to VVS-↓SVR, and venomotor
properties were similar to control. Combined splanchnic pooling and reduced SVR produced the earliest faints among the VVS
groups.
Conclusions-—Both ↓CO and ↓SVR occur in young VVS patients. ↓SVR is predominant in VVS and is caused by impaired splanchnic
vasoconstriction. ( J Am Heart Assoc. 2017;6:e004417. DOI: 10.1161/JAHA.116.004417.)
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S yncope is defined by rapid onset of transient loss ofconsciousness and postural tone attributed to cerebral
hypoperfusion with spontaneous recovery.1 The majority of
syncope is attributed to simple faint, denoted vasovagal
syncope (VVS),2 and often triggered by upright posture.
Upright posture causes subdiaphragmatic gravitational blood
pooling, primarily within the venous system, that reduces
central blood volume.3 In the absence of skeletal muscle
pump activity, this reduces venous return and cardiac output
(CO). Blood pressure is maintained by baroreceptor-mediated
increases in systemic vascular resistance (SVR), passive
elastic recoil of venous blood, active splanchnic venocon-
striction,4 and an increase in heart rate (HR). Splanchnic vaso-
and venoconstriction are integral to maintaining upright blood
pressure (BP).5 A representative time course of changes in BP
and HR for a young VVS patient during 70-degree upright tilt
testing is shown in Figure 1.
Typically, we discern 4 phases of cardiovascular
response.6–8 Following initial orthostatic hypotension,9 BP
stabilizes (phase 1) for a variable number of minutes.
Thereafter, gradually progressive early hypotension occurs
(phase 2) associated with reflexively increased HR. Because
mean arterial pressure (MAP)=CO9SVR, decreasing BP during
phase 2 could be attributed to decreasing CO, decreasing
SVR, or a combination of both. During phase 3, there is a
rapid decrease in BP and HR with circulatory collapse caused
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by vasodilation related to withdrawal of sympathetic nerve
activity and loss of adrenergic vasoconstriction.10 Phase 4
recovery of BP occurs rapidly once supine.
Previous studies of adult VVS using pulse contour analysis of
finger photoplethysmographic waveforms (ModelFlow method)
showed that phase 2 hypotension was attributed to decreasing
CO attributed, for the most part, to excessive blood pooling in
the splanchnic circulation5 whereas SVR was maintained or
increased.11 Previous studies of children and adolescents with
VVS using ModelFlow methods showed that phase 2 hypoten-
sion was attributed to decreasing SVR whereas CO was
maintained.12 In contrast, other experiments using electrical
impedance plethysmography methods to measure changes in
regional blood flow and blood volume in young VVS patients
showed reduced CO and increased SVR.13,14
To resolve these apparently contradictory results, we
applied both finger photoplethysmographic and impedance
plethysmographic techniques to a single group of young VVS
patients and set a priori criteria for “reduced CO” and
“reduced SVR.”
We hypothesized that phase 2 hypotension occurs in
young VVS patients either by decreased SVR (↓SVR),
decreased CO (↓CO), or a combination of decreased SVR
and decreased CO (↓SVR+↓CO). We further hypothesized that
VVS patients with ↓CO have excessive splanchnic pooling




To test these hypotheses, we recruited 48 patients with a
history of recurrent fainting (30 female, 16.11.0 years)
ranging in age from 12 to 19 years. Fainters were referred to
our center for investigation after experiencing at least 2
episodes of fainting within the last 12 months. Data were
analyzed for patients who experienced VVS during our upright
tilt procedure, and who identified the presyncopal prodrome,
and the postsyncopal postdrome as similar to their outpatient
experiences. We also recruited 10 healthy nonfainting control
subjects (6 female, 16.31.1 years). There were no differ-
ences in the ages, weight, and body mass index (BMI)
between the groups.
Syncope patients gave a medical history and underwent a
physical examination, electrocardiography, echocardiography,
and prolonged monitoring, if needed, to exclude cardiac
causes for syncope. Control subjects reported no clinical
illnesses and had never fainted.
The diagnosis of VVS was primarily based on clinical history.
Key diagnostic features encompassed predisposing situations,
prodromal symptoms, physical signs, and postdrome recovery
and symptoms.2 In all patients, past fainting had been induced
by prolonged standing and in 6 patients it was also triggered by
noxious stimuli. Prodromal features included pallor, lighthead-
edness, nausea with abdominal discomfort, diaphoresis, a
feeling of warmth, visual scotomata, or frank loss of vision.
Following the faint, unconsciousness lasted less than 30 sec-
onds when supine and most patients felt fatigued afterward.
Exclusion criteria for participation in this study included any
infectious or systemic disease (including other cardiovascular
disease), other forms of orthostatic intolerance, competitive
athletic training, recent long-term bed rest, use of nicotine-
containing products, or pregnancy within the last year. Any
medication for syncope was stopped for at least 2 weeks
before participation in this study. No subjects were taking












































Figure 1. Head-up tilt table test for a vasovagal syncope
patient. Mean arterial pressure (MAP) is shown in the top panel
and heart rate (HR) in the bottom panel. Fiducial points are
marked at the top. MAP and HR follow a characteristic time
course comprising 4 stages: early blood pressure (BP) stabiliza-
tion (phase 1, fiducial point 2); “progressive early hypotension”
with BP slowly declining as HR increases (fiducial points 3–5);
syncope with hypotension and bradycardia (phase 3, fiducial point
6). Phase 4 recovery of BP occurs within 30 seconds once supine.
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All subjects refrained from caffeine and xanthine-contain-
ing products for at least 72 hours before testing. All subjects
were instructed to fast for at least 4 hours before testing. This
study was approved by the Institutional Review Board of New
York Medical College (Valhalla, NY). All subjects aged 18 or
older signed an informed consent; those younger than 18
assented to participate and their parent or legal guardian
signed an informed consent.
Protocol
Subjects arrived at our climate-controlled center at 9:30 AM
after a 4-hour fast and were instructed about the tests and
instrumentation. Subjects were then instrumented while
supine. Beat-to-beat BP was measured by Finometer finger
photoplethysmograph (FMS, Amsterdam, the Netherlands) on
the right forefinger or middle finger. The Finometer uses the
ModelFlow algorithm to estimate beat-to-beat CO by pulse-
wave analysis. Before experiments began, ModelFlow CO was
calibrated against an Innocor inert gas rebreathing CO
measurement (Innovision, Glamsbjerg, Denmark) while
supine. We continuously computed SVR by dividing the time
average arterial pressure (MAP) by the ModelFlow CO
averaged over each cardiac cycle. We also computed the
pulse pressure (PP) for each cardiac cycle by subtracting the
diastolic (DBP) from the systolic BP (SBP). We placed paired
electrodes using anatomical landmarks to estimate thoracic,
splanchnic, pelvic, and calf segmental blood volumes, blood
flows, and vascular resistance by impedance plethysmogra-
phy.15 Respiratory plethysmography (Respitrace; NIMS Scien-
tific, Miami Beach, FL) and capnography (Smith Medical PM,
Waukesha, WI) measured changes in respiration and end tidal
carbon dioxide (ETCO2). An electrocardiograph measured HR
from the beat-to-beat cardiac electrical interval. Signals were
acquired at 200 samples/s, multiplexed, and analog-to-digital
converted using custom software. These measurements are
routine during our tilt-table studies.
Following instrumentation, subjects remained awake and
supine for 30 minutes to acclimate. Baseline data comprised
continuously measured HR, BP, ETCO2, CO, SVR, and thoracic,
splanchnic, pelvic, and calf segmental impedances and rate of
change of impedances by impedance plethysmography. For
purposes of comparison, we used averaged data for the
10 minutes immediately preceding tilt to determine baseline,
supine values.
After supine data collections were complete, subjects were
tilted upright to 70 degrees. Duration of upright tilt was
10 minutes in healthy volunteer controls whereas VVS
patients remained upright until fainting was imminent. Tilt
was performed without pharmacological provocation. Contin-
uously measured HR, BP, ETCO2, CO, SVR, and impedance
data were recorded for off-line analysis. We limited the head-
up tilt (HUT) testing in healthy volunteer subjects to
10 minutes. We have previously demonstrated that this is
sufficient time for the comparison of orthostatic changes
between control and VVS subjects.11,14 Also, near fainting
occurred, on average, between 10 and 11 minutes after
starting upright tilt in VVS patients.
VVS patients had a clinical history of fainting, and each
developed a classic vasovagal faint with hypotension followed
by bradycardia during tilt-table testing. During this investiga-
tion, VVS patients were tilted back to supine when fainting
was imminent, or when requested. Imminent postural vaso-
vagal syncope was defined by a tilt-induced decrease in mean
arterial pressure (MAP) to <60 mm Hg or a decrease in SBP
<70 mm Hg associated with symptoms of impending loss of




In accord with our previous work,14 we analyzed results at
fiducial time markers rather than at specific time points.
Fiducial markers identified times at which physiological
events occurred. Although the actual time between physio-
logical events varied, fiducial markers allowed for the study of
events with corresponding responses specific for each fainter.
Six defining events were determined from the BP trace of
each VVS subject, represented by 1 subject (Figure 1).
The first fiducial point was baseline “supine.” The second
was chosen to be mid phase 1 “1 minute” after HUT to
avoid including the initial transient decrease in BP and
increase in HR that follows orthostasis16 with rapid recovery
in both healthy volunteers and VVS patients. This has been
denoted “initial orthostatic hypotension” and relates to a
period of mechanical dysequilibrium caused by caudal central
blood translocation and the normal lag in sympathetic
vasoconstriction.9 The third point was defined in fainters at
the onset of the gradual decline in BP and is designated
“early” this is the start of phase 2. BP falls off rapidly and
abruptly at the transition between phase 2 and 3, which
defined the “late” point (point 5), just before faint. We defined
an additional “mid” point midway between “early” and “late”
(point 4). The last fiducial point (point 6), designated “faint,”
was at the time of faint for VVS patients, or at 10 minutes for
control subjects. Healthy control subjects did not have a
significant fall in BP and did not faint. We defined equivalent
fiducial time points for healthy volunteers by taking the actual
time of occurrence of each fiducial marker event in VVS
patients divided by the time from onset of tilt to determine the
fractional time to marker, averaging that over all fainters, and
multiplying by 10. Control subjects and VVS subjects were
thus compared at equivalent times to allow for a uniform
DOI: 10.1161/JAHA.116.004417 Journal of the American Heart Association 3





















evaluation of hemodynamic quantities across groups, and all
subjects were represented at each fiducial point.
A priori VVS patient stratification based on ModelFlow
criteria
CO decreases during tilt in healthy volunteers.17 Past
experiments using ModelFlow methods demonstrated an
average maximum reduction of CO during upright tilt for
10 minutes of 11.25.1% (SD) in 58 comparable young
control subjects. This CO reduction in control subjects is
similar to values reported by de Jong-de Vos van Steenwijk
et al.12
We defined 3 groups of VVS based on a priori criteria: (1)
decreased CO but not SVR (designated “↓CO”), defined by CO
decreased by at least 11.2% from baseline by “late” phase 2);
(2) decreased SVR but not CO (designated “↓SVR”) during tilt if
ModelFlow estimated SVR decreased below baseline by “late”
phase 2; and (3) decreased CO+SVR (designated ↓CO & ↓SVR)
comprised the remainder of patients. All VVS patients fell
within these group definitions. Subjects were therefore
assigned to 1 of the groups based on post-hoc analyses of
data recorded during tilt-table testing.
Measurement of changes in segmental blood volumes
Changes in segmental or regional blood volumes and
segmental blood flows used impedance plethysmography
(IPG) using a tetrapolar high-resolution 4-channel digital
impedance plethysmograph (UFI, Morro Bay, CA) to measure
impedances and the rate of change of impedances, as
previously described.18,19 These quantities were obtained
within 4 anatomical segments defined by electrode placement
on anatomical landmarks that delimit respective regional
circulations. These were designated the thoracic segment
(supraclavicular area to xyphoid process), the splanchnic
segment (xyphoid process to iliac crest), the pelvic segment
including lower pelvis to the knee (iliac crest to knee), and the
leg or calf segment (upper calf just below the knee to the
ankle).
Measurement of changes in segmental blood flow
IPG was also used to estimate segmental or regional blood
flows.20 These methods have been validated in our laboratory
against the reference standard indocyanine green dye tech-
nique and calf venous occlusion plethysmography and were
used to measure leg, thoracic, and splanchnic blood flow, as
previously described.15,21
Statistical Analysis
All data were digitized and stored and were analyzed offline
with custom software. VVS patients were partitioned into 3
groups—VVS-↓CO, VVS-↓SVR, and VVS-↓CO & ↓SVR—as
previously described. Including the healthy volunteer control
group, there were 4 subject groups for comparison.
Baseline data for BP, HR, CI, SVR, and ETCO2 are shown in
absolute units in Table. We also analyzed time to faint for each
of the 3 VVS groups. These were compared among the groups
by 1-way ANOVA. A significant omnibus ANOVA test was
followed by post-hoc pair-wise comparisons among groups.
Scheffe’s test was used to adjust the pair-wise comparisons
for multiple comparisons. All tabular results are reported as
meanSEM.
Graphic data are shown as percent of baseline expressed
as meanSEM. Data were obtained from original time series
averaged over 15-second intervals centered at the fiducial
markers. Data were collected and analyzed by the same
investigator throughout. We used repeated-measures ANOVA
to compare group- and time-dependent differences at fiducial
points. We assigned greatest importance to “group9time
effects” representing the interaction of subject group with
time-dependent changes during upright tilt. We assumed a
covariance structure of compound symmetry. Reported P
Table. Baseline Hemodynamics
Control All Fainters ↓CO ↓CO &↓SVR ↓SVR
SBP, mm Hg 1133 1152 1174 1115 1153
DBP, mm Hg 612 572 593 595 552*
MAP, mm Hg 782 761 793 765 752
HR, bpm 636 696 705 648 625
CI, L/min per m2 4.70.5 4.80.2 5.10.5 4.40.4 4.70.3
SVR, mm Hg/L per minute 17.51.6 17.20.8 16.81.1 18.01.3 18.11.2
ETCO2, Torr 411 431 411 421 441
CI indicates cardiac index in L/min per m2 (liters per minute per square meter body surface area); DBP, diastolic blood pressure in mm Hg (millimeters of mercury pressure); ETCO2, end
tidal carbon dioxide in Torr; HR, heart rate in bpm (beats per minute); MAP, mean arterial pressure in mm Hg (millimeters of mercury pressure); SVR, systemic vascular resistance in
mm Hg/L per minute (millimeters of mercury pressure per liter per minute); SBP, systolic blood pressure in mm Hg (millimeters of mercury pressure).
*P<0.05 compared to control.
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values reflect the interaction term using the Greenhouse–
Geisser correction. Statistical significance was set at P≤0.05.
Results were calculated by using GraphPad Prism software
(version 4.0; GraphPad Software Inc., La Jolla, CA).
Results
Baseline Supine Data
Supine data are displayed in Table, which shows data for
controls, for all VVS patients combined, and for VVS patients
stratified into the 3 subgroups on the basis of upright CO and
SVR. There were no differences between the age, sex, and
BMI of the 3 subgroups compared to controls. Stratified data
are used for ANOVA. There were no baseline differences in
SBP, HR, CI, SVR, or ETCO2 between control and VVS groups.
DBP was significantly reduced, compared to control
(P<0.025), for VVS-↓SVR patients.
Upright Tilt Data
Time to faint
Healthy control subjects did not experience symptoms of
orthostatic intolerance nor did they faint. There were 12
patients belonging to VVS-↓CO, 11 belonging to VVS-
↓CO&↓SVR, and 25 belonging to the VVS-↓SVR group. VVS-
↓CO&↓SVR resulted in the most precipitous decreases in BP
during phase 2 and the shortest mean time from tilt up to
syncope, averaging 35050 seconds, compared to
902118 seconds for VVS-↓CO and 674102 seconds for
VVS-↓SVR (P=0.013 for ANOVA; P=0.010 for VVS-↓CO vs
VVS-↓CO&↓SVR). Average time to faint inclusive of all groups
was 64070 seconds (10 minutes, 40 seconds).
Representative tracings during tilt, VVS groups
Figure 2 shows BP, HR, CO, and SVR for representative
subjects belonging to each experimental group. There is an
increase in HR in all during orthostatic stress. There is a gradual
falloff in BP followed by rapid hypotension and bradycardia in all
VVS patients, but not in controls. The initial step decrease in CO
on tilt-up in the VVS-↓CO patients is attributed to the effects of
gravity. CO thereafter progressively decreases throughout tilt
whereas SVR increases. CO falls initially in the VVS-↓CO &↓SVR
patient then rises slightly and decreases during the remainder
of tilt. SVR initially increases on tilt-up, but then decreases
during the remainder of tilt, whereas CO falls. CO increases
above baseline in the VVS-↓SVR patient whereas SVR declines
monotonically. At the time of imminent faint, all VVS patients
experienced hypotension followed afterward by bradycardia
whereas SVR and CO decreased. Averaged data showing
percent changes in hemodynamic quantities from baseline
values are shown in Figures 3 through 6.
HR, MAP, PP
Figure 3 shows that HR fell precipitously in all VVS patients at
the time of faint. MAP and PP decreased significantly more
throughout tilt in all VVS groups (P<0.025) compared to
control subjects.
Regional blood flows
As shown in Figure 4, CO decreased progressively and more
rapidly in VVS-↓CO and VVS-↓CO&↓SVR compared to control









Figure 2. Blood pressure (BP), heart rate (HR), cardiac output (CO), and systemic vascular resistance (SVR) for representative subjects during
head-up tilt table testing. Shown from left to right are healthy control subjects (Control), VVS syncope patients who have a decrease in CO but
no decrease in SVR designated (VVS-↓CO), VVS syncope patients who have a decrease in CO and SVR during tilt designated (VVS-↓CO &↓SVR),
and VVS syncope patients who have a decrease in SVR during tilt but no decrease in CO designated (VVS-↓SVR). There is an increase in HR rate
with orthostasis in all subjects. BP first gradually declines, followed by rapid hypotension and bradycardia in all VVS. VVS-↓CO &↓SVR patient
has a decrease in CO and initial increase in SVR, which then decreases for the remainder of tilt. CO in the VVS-↓SVR patients trends above
baseline whereas SVR declines monotonically. At the time of faint, all VVS patients experienced hypotension followed rapidly by bradycardia
whereas SVR and CI decreased. CI indicates cardiac index; VVS, vasovagal syncope.
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(P<0.01). CO was significantly increased above control in
VVS-↓SVR before faint (P<0.001). Control subjects had an
initial decrease in CO by 1 minute, which was thereafter
sustained. Splanchnic blood flow decreased from baseline
(P<0.001) in control and in VVS-↓CO and VVS-↓CO&↓SVR.
However, splanchnic blood flow increased progressively
during tilt in VVS-↓SVR (P<0.0001). Splanchnic blood flow
trended lower in VVS-↓CO compared to control.
Pelvic blood flow decreased in all groups and was not
different from control in VVS-↓SVR. Pelvic blood flow was
reduced, compared to control, during tilt in VVS-↓CO and VVS-
↓CO&↓SVR (P<0.001). Calf blood flow decreased similarly
with tilt for all subjects.
Regional blood volumes
Figure 5 shows that the percent of central blood volume (%
CBV) decreased in all subjects. %CBV decreased significantly
more than control (P<0.01) in all VVS patients until just before
faint. Splanchnic blood volume increased during tilt in all
subjects, but was significantly greater than control for VVS-
↓CO and VVS-↓CO&↓SVR (P<0.001). Splanchnic blood volume
was not different from control in VVS-↓SVR. Pelvic blood
volume increased similarly in all groups during tilt. Calf blood
volume increased with tilt for all subjects. Calf blood volume
increased more than control in VVS-↓CO and VVS-↓SVR
(P<0.025).
Regional arterial resistances
Figure 6 shows that SVR increased by 1 minute above
baseline for all subjects, but then decreased progressively
in VVS-↓CO&↓SVR and VVS-↓SVR. SVR increased similarly to
control in VVS-↓CO by definition. Splanchnic resistance
increased similarly in control and VVS-↓CO up to the time
of faint when RSpl decreased in all VVS. Following an initial
increase, splanchnic resistance decreased in VVS-↓SVR and
VVS-↓CO&↓SVR compared to control (P<0.025). At no time
did RSpl significantly increase above supine in VVS-↓SVR.
Pelvic resistance increased in all groups and was larger
than control in VVS-↓CO until the time of faint. RPelv
decreased for all VVS at the time of faint. Calf resistance
increased initially from baseline in all subjects, then
decreased in all VVS compared to control.
Discussion
VVS occurs when arterial pressure decreases below that
which provides adequate cerebral blood flow to maintain
consciousness. We have previously shown that syncope is
defined by a decrease in cerebral blood flow that is
accompanied by a loss of cardiovagal baroreflex and effective
cerebral autoregulation.22,23
In the current studies, we have partitioned the HR-BP
response to an orthostatic challenge into 3 phases. During
phase 1, there is BP stability. In phase 2, there is a slow fall in
BP and an increase in HR. Phase 3 is characterized by a rapid
fall in BP that is accompanied with bradycardia. The












































Figure 3. Averaged heart rate (HR), mean arterial pressure
(MAP), and pulse pressure (PP) during upright tilt. HR appears in
the upper panel, MAP in the middle panel, and PP in the lower
panel at designated fiducial time points. Control data are shown
as open circles (○), VVS-↓CO data are shown as black boxes (■),
VVS-↓CO &↓SVR are shown as black triangles (▲), and VVS-↓SVR
are shown as diamonds (♦). HR fell precipitously in all VVS
patients at the time of faint. MAP and PP decreased significantly
throughout tilt in all VVS (P<0.025) compared to control subjects,
as shown by the asterisk (“*”). VVS indicates vasovagal syncope.
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understood, but may involve non-heart-rate–related reduc-
tions in BP that can result from inadequate cardiac preload,
inadequate ventricular contraction, or reductions in SVR. We
sought to elucidate which of these mechanisms were
responsible for syncope in this age group and provide data
by measuring a wide variety of factors, including HR, CO, SVR,
ETCO2, and regional impedance data.
All the responses observed in this study were of the
combined vasovagal variety, with a combination of hypoten-
sion and HR reduction. We chose to segregate them into 3
groups; ↓CO, ↓SVR, and ↓CO &↓SVR. The large preponderance
(25 of 48) belonged to the ↓SVR group. Importantly, MAP
reductions were similar in all 3 groups and distinctly different
from the controls that had no significant change in MAP, but
the mechanisms underlying the reduction varied between the
groups. And, given that VVS by these constructs takes more
than 1 hemodynamic form, our results will be discussed in
relation to each form.
Decreased CO Without Decreased SVR Occurs in
a Subset of Young VVS Patients and Is Related to
Splanchnic Blood Pooling
A minority of young fainters in our cohort (those with VVS-
↓CO; 11 of 48) had phase 2 hypotension determined by
reduced venous return, similar to that reported in adults.11
This contrasts with a previous study, showing reduction of
SVR as the sole mechanism of VVS in children and
adolescents.12 Reduced venous return is consequent to
excessive splanchnic blood pooling within the capacitance
vessels of the liver and mesentery13 and, to a lesser extent,
within the calf, but not within the pelvic vasculature where
pooling remains similar to control. Venous pooling accounts
for the excessive central hypovolemia that characterizes
VVS.24 SVR is increased because of increased pelvic vascular
resistance and splanchnic vasoconstriction. This also implies
that splanchnic pooling in VVS-↓CO patients occurs in the
absence of decreased splanchnic vasoconstriction. This could
occur were there an increase in splanchnic capacitance
(decreased venoconstriction). However, venoconstriction and














































































Figure 4. Regional blood flows during upright tilt. The top
panel shows the cardiac output (CO) in L/min, the second
shows percent change in splanchnic blood flow (%Δ Splanchnic
Blood Flow), the third panel shows percent change in pelvic
blood flow (%Δ Pelvic Blood Flow), and the bottom panel shows
percent change in calf blood flow (%Δ Calf Blood Flow). Control
data are shown as open circles (○), VVS-↓CO data are shown as
black boxes (■), VVS-↓CO &↓SVR are shown as black triangles
(▲), and VVS-↓SVR are shown as diamonds (♦). CO decreased
progressively and more rapidly in VVS-↓CO, and VVS-↓CO&↓SVR
compared to control (P<0.01), as shown by the asterisk (“*”).
Calf Blood Flow decreased similarly with tilt (P<0.001) for all
subjects, as shown by the asterisk (“*”)*. SVR indicates
systemic vascular resistance; VVS, vasovagal syncope.
DOI: 10.1161/JAHA.116.004417 Journal of the American Heart Association 7





















Despite the significantly larger increase in HR compared to
the other 2 groups, these subjects had an observed reduction
in CO. This suggests that the increased HR was unable to
compensate for MAP reduction, or perhaps even contributed
by reducing diastolic filling time below that appropriate for the
relevant preload and ventricular state. In addition, these
patients had the largest reduction in central volume and
largest increase in splanchnic pooling of the 3 groups,
contributing to reduced ventricular filling and reduced CO.
This group of patients therefore may be most likely to benefit
from hydration therapies, such as increased oral fluid intake
and/or mineralocorticoid therapy to increase fluid retention.
Decreased SVR Occurs in a Majority of Young
VVS Patients
The majority (75%) of our young VVS patients had reduced
SVR during phase 2 presyncope, including 23% who also had
reduced CO.
VVS-↓SVR Patients
VVS-↓SVR patients had no reduction in CO by definition. There
was no excessive splanchnic pooling compared to healthy
control subjects. Rather unexpected, however, was the finding
of increased CO above baseline in many patients. There was a
large increase in splanchnic blood flow above supine baseline
consequent to marked reduction in splanchnic vascular
resistance. Because there were no differences in pelvic or
calf blood flows in VVS-↓SVR compared to control, elevated
splanchnic blood flow sustains or increases venous return
above baseline, whereas BP falls because of progressive
reduction in cardiac afterload. Reduced splanchnic vasocon-
striction should passively increase hepatic and mesenteric
venous pressure and thus venous pooling.26 The absence of
increased splanchnic pooling during upright tilt suggests that
the mesenteric and hepatic venous pressure is not increased,
despite arterial vasodilation, that is, the physiological charac-
teristics of an acute arteriovenous shunt resulting in main-
tained or even increased venous return.27 If true, how can
central hypovolemia occur in VVS-↓SVR to a similar degree as












































































Figure 5. Percent change in regional blood volumes during
upright tilt. The top panel shows the percent change in central
blood volume (%Δ Central Blood Volume), the second shows
percent change in splanchnic blood volume (%Δ Splanchnic Blood
Volume), the third panel shows percent change in pelvic blood
volume (%Δ Pelvic Blood Volume), and the bottom panel shows
percent change in calf blood volume (%Δ Calf Blood Volume).
Control data are shown as open circles (○), VVS-↓CO data are
shown as black boxes (■), VVS-↓CO &↓SVR are shown as black
triangles (▲), and VVS-↓SVR are shown as diamonds (♦).
Splanchnic blood volume increased during tilt in all subjects,
was greater than control for VVS-↓CO, and VVS-↓CO&↓SVR
(P<0.001) as shown by the asterisk (“*”), and not different from
control in VVS-↓SVR. CO indicates cardiac output; SVR, systemic
vascular resistance; VVS, vasovagal syncope.
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Hemodynamics properties of an arteriovenous shunt
The chronic compensated physiological state of AV shunt
includes reduced cardiac afterload, increased blood volume,
and increased cardiac size with eccentric left ventricular
hypertrophy.28 Acutely, by unloading the heart, an AV shunt
initially reduces central blood volume while maintaining or
increasing CO; the cardiac silhouette shrinks on x-ray.29 Similar
changes occur during upright tilt of healthy volunteers
subjected to whole-body heating: central blood volume is
decreased whereas CO remains elevated30; SVR is greatly
reduced and orthostatic stress is poorly tolerated.31
Splanchnic hemodynamic properties are distributed
Arterial vasoconstriction. The splanchnic vasculature has
uniquely distributed arterial resistance, venous capacitance,
and venous resistance properties. Arterial vasoconstriction
can occur at the inflow of each splanchnic organ (stomach,
small intestine, large intestine, liver, spleen, and pancreas)
and is primarily mediated by sympathetic nerves releasing
norepinephrine, which binds to a1-, a2-adrenergic receptors
of the vascular smooth muscle. Splanchnic arterial vasodila-
tion through b2 adrenergic receptors can also occur.32
Venous capacitance. In humans, splanchnic venous capac-
itance resides within the mesenteric venous system and the
liver25,33 which are aligned in series by the portal vein. Portal
vascular resistance is ordinarily low and hepatic andmesenteric
pressures are similar.34 The hepatic and mesenteric capaci-
tances have both a1- and a2-adrenergic receptors contributing
to active venoconstriction, but lack b2 receptors.35
Venous resistance. Splanchnic venous resistance is localized
at the hepatic veins, which serves a sphincter-like function.36
Hepatic venoconstriction maintains hepatic and mesenteric
capacitances at pressures a little higher than inferior vena cava
pressure. There are few hepatic venous a-adrenergic receptors,
but abundant b2 receptors that produce nitric-oxide–dependent
venodilation.33 Splanchnic pooling can be prevented if sufficient
hepatic vein dilation equalizes hepatic and mesenteric venous
pressures with inferior vena cava (IVC) pressure.37
Vasovagal syncope is associated with progressive
increase in epinephrine in young patients
During orthostatic stress, circulating epinephrine increases in































































Figure 6. Percent change in regional arterial vascular resistance
during upright tilt. The top panel shows the percent change in SVR,
the second shows percent change in splanchnic resistance (%
DRSplanchnic), the third panel shows percent change in pelvic
resistance (%DRPelvic), and the bottom panel shows percent change
in calf resistance (%DRcalf). Control data are shown as open circles
(○), VVS-↓CO data are shown as black boxes (■), VVS-↓CO &↓SVR
are shown as black triangles (▲), and VVS-↓SVR are shown as
diamonds (♦). CO indicates cardiac output; SVR, systemic vascular
resistance; VVS, vasovagal syncope.
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concentrations further enhances splanchnic arterial vasodila-
tion through b2-receptors40 whereas hepatic venodilation
equalizes hepatic with IVC venous pressure preventing
splanchnic pooling.41 Instead, a short-lived arteriovenous
shunt would be created, supporting CO at the expense of SVR
and BP, explaining our findings.
VVS-↓CO&↓SVR Patients
Patients with VVS-↓CO&↓SVR had splanchnic and calf blood
pooling comparable to pooling observed in VVS-↓CO
patients, combined with the afterload reduction of VVS-
↓SVR. In VVS-↓CO&↓SVR patients, splanchnic arterial
vasodilation occurred to a lesser extent than in VVS-↓SVR
and estimated venous properties appear to be similar to
control. The combined effects of splanchnic pooling and
reduced SVR resulted in the earliest faints among the VVS
groups.
Limitations
Fiducial time markers facilitate comparison of subjects
undergoing similar physiological phenomena at different
times (eg, the onset of rapid hypotension-bradycardia just
before faint). However, it removes the absolute time depen-
dence of the observed phenomena.
Although there were no differences between the age, sex,
and BMI of the 3 subgroups compared to controls, the number
of subjects in each group was relatively small. It is therefore
possible that differences in these factors could be potential
confounding variables.
We did not measure absolute blood volume or central
blood volume while supine. This can affect the hemodynamics
during vasovagal syncope.42
Impedance plethysmography of the splanchnic vasculature
cannot distinguish blood pooling among the splanchnic
organs (eg, liver vs mesenteric). Also, the technique measures
fractional change in regional blood volumes and blood flows,
which have been validated against reference standards in
previous studies.15,21
We studied the healthy volunteers during 10 minutes of
tilt, which was considered appropriate based on previous
studies.43 Increasing the time of HUT could potentially yield
different information. However, the mean time to VVS was 10
to 11 minutes, and our results inform primarily on phase 2
hypotension, which started before 10 minutes in all VVS
patients.
The Finometer yields relative measures of CO. Whereas we
standardized supine CO against inert gas rebreathing CO,
standardization was not performed during the tilt because the
technique requires deep breathing, which would alter hemo-
dynamics.
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